Stock ABOS ACUMEN PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Acumen Pharmaceuticals, Inc.

Equities

ABOS

US00509G2093

Delayed Nasdaq
Other stock markets
 13:36:42 2024-05-01 EDT 		5-day change 1st Jan Change
3.175 USD -1.40% Intraday chart for Acumen Pharmaceuticals, Inc. -0.16% -17.32%
04-04 Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug MT
04-04 Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ABOS Stock
  4. Revisions Acumen Pharmaceuticals, Inc.